Long-Term Outcome and Morbidity After Treatment With Accelerated Radiotherapy and Weekly Cisplatin for Locally Advanced Head-and-Neck Cancer: Results of a Multidisciplinary Late Morbidity Clinic
- 1 November 2011
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 81 (4) , 923-929
- https://doi.org/10.1016/j.ijrobp.2010.07.013
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Current State-of-the-Art for Concurrent ChemoradiationSeminars in Radiation Oncology, 2009
- Multidisciplinary Management of Locally Advanced SCCHN: Optimizing Treatment OutcomesThe Oncologist, 2008
- Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)International Journal of Radiation Oncology*Biology*Physics, 2008
- Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancerHead & Neck, 2006
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysisPublished by Elsevier ,2006
- Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14Journal of Clinical Oncology, 2005
- Altered fractionation and combined radio-chemotherapy approachesEuropean Journal Of Cancer, 2003
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000
- Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 1998